Pope Leo XIV: Undergoes Successful Lobectomy in Rome, Vatican Confirms

Pope Leo XIV: Undergoes Successful Lobectomy in Rome, Vatican Confirms

The Holy See has officially confirmed that Pope Leo XIV has been diagnosed with lung adenocarcinoma, a form of lung cancer, following a successful surgical procedure carried out on Tuesday at Rome's Agostino Gemelli University Hospital. The 71-year-old pontiff underwent a lobectomy to resect a cancerous nodule along with the lower lobe of his right lung after pre-operative examinations detected localized abnormalities. According to an official medical bulletin released by the Vatican press office, the surgery concluded without any intraoperative complications, and the American pontiff has returned to his recovery suite under close medical observation.

Inside the 90-Minute Procedure: Dr. Stefano Margaritora Leads Surgical Team

Medical authorities provided key clinical details surrounding the surgical intervention in the Italian capital:

  • Confirmed Adenocarcinoma: While preoperative screening had raised suspicions of malignancy, tissue analysis conducted during the operation formally established the diagnosis of lung adenocarcinoma.

  • Surgical Precision: The pontiff remained in the operating suite for roughly three hours, with the core surgical intervention taking approximately 90 minutes under the direction of Dr. Stefano Margaritora, Chief of Thoracic Surgery at Gemelli Hospital.

  • Complication-Free Execution: Vatican spokespersons confirmed the procedure adhered strictly to scheduled clinical protocols, with the Pope stabilizing smoothly as anesthesiology teams concluded post-operative observation.

  • High Spirits on Arrival: Displaying calm resolve ahead of the procedure, Pope Leo entered Gemelli Hospital through the main entrance on Tuesday morning, taking a moment to wave to dozens of gathered faithful and well-wishers.

Advanced Diagnostics and Robotic Techniques: The Role of Minimally Invasive Technology

Prior to the operation, clinical specialists explored advanced surgical platforms to streamline diagnosis and resection:

  • Robotic Bronchoscopy Systems: Leading specialists evaluated precision guidance platforms, including the ION robotic bronchoscopy system, which allows pulmonologists to sample peripheral nodules as minute as three millimeters.

  • Minimally Invasive Interventions: Dr. Lorenzo Spaggiari, Director of Thoracic Surgery at Milan's European Institute of Oncology, highlighted that modern protocols frequently permit immediate biopsy confirmation followed directly by segmental resection or complete lobectomy under a single general anesthesia window.

  • Favorable Prognosis for Localized Disease: Addressing the development, Dr. Stephen Liu of Georgetown University’s Lombardi Comprehensive Cancer Center noted that an absence of surgical complications serves as an encouraging initial indicator, with long-term prognosis relying heavily on final histological staging.

Recovery Schedule and Papal Engagements Frozen Through October 20

The health disclosure marks the first major medical challenge of Pope Leo XIV's 17-month pontificate:

  • Week-Long Inpatient Care: The Vatican indicated that the pontiff is expected to remain hospitalized for roughly seven days to ensure steady tissue healing and respiratory monitoring.

  • Temporary Quarters During Renovations: Pope Leo is accommodated in a private clinical suite adjacent to the traditional 10th-floor papal apartment—which includes a dedicated chapel—as that wing is currently undergoing planned infrastructural renovations.

  • Apostolic Engagements Paused: All public general audiences, private diplomatic meetings, and liturgical celebrations have been officially canceled through October 20 to afford the Holy Father undisturbed convalescence before doctors review subsequent therapy options.